The u r i n a r y excretion o f the unique amino acid, 3-methyl h i s t idine (3MH), has been proposed as a marker o f endogenous p r o t e i n catabolism and an index o f a p a t i e n t ' s metabolic state. Yet, the mechanisms o f the renal handling o f 3MH remain unclear. Consequently, we determined the simultaneous clearance o f 3MH (C3MH) and i n u l i n (Gin) i n r a t s .
3.7%. I n f i v e volume expanded animals, the percent 3MH reabsorbed was not s i g n i f i c a n t l y a l t e r e d (80 + 5.0%).
To confirm n e t reabsorption, 3MH combined w i t h i n u l i n was microinjected i n t o proximal tubules o f surface nephror I n u l i n recovery from the microinjected kidney averaged 102 k 9% while the recovery o f 3MH was only 74 * 6% (P < 0.01). The percent o f 3MH reabsorbed had no r e l a t i o n s h i p t o the quantity o f 3MH i njected, suggesting t h a t there i s no Tm f o r 3MH.
This study c l e a r l y demonstrates t h a t : 1) the renal clearance o f 3MH i s less than t h a t o f i n u l i n , 2) n e t tubular reabsorption occurs over a wide range o f f i l t e r e d loads o f 3MH and 3) a Tm f o r reabsorption o f t h i s amino acid metabol i t e could n o t be documented. These factors must be considered i n using urinary excret i o n o f 3MH as a marker o f n u t r i t i o n a l status.
THE EFFECTS OF FORMULA (F) COMPOSITION AND VOLUME ON GASTRIC EMPTYING PATTERNS (GEP) IN THE PRETERM IN-
639 FANT (PI). Robert Shaw and -Erenberg, U. of Iowa Coll. Med., Dept, Ped., Iowa City.
GEP may be influenced by the test meal volume ( V ) and its composition. To determine the effects of F composition and V on GEP, 4 PI, 1.3-1.7 kg, were fed consecutive alternate feedings of Similac 24 (S) or LBW (L) at 20 mllkg using polyethylene glycol (PEG), a non-toxic, non-absorbable marker. Studies were repeated weekly for 3 wks. Four other PI, 1.1-1.8 kg, were fed S at consecutive alternate V of 10 or 30 mllkg. All feedings were delivered by nasogastric tube over a 5-rnin period, 3 hrs apart, with the PI in the supine position. 1 ml of PEG was added to each ml of F. 1-ml gastric aspirates were obtained at 10-min intervals for 1 hr and replaced with equal V of F containing 4 mg PEG per ml F. Gastric residual volumes (GRV) were calculated from equations for double sampling. In PI fed 20 ml/kg, the mean GRV at 10 min was 35% for S and 46% for L, and neither changed significantly thereafter. There was no significant difference in the mean GRV between PI fed 20 mllkg S or L during the test period. In PI fed S, 10 mllkg, the mean GRV was 52% at 10 min and did not change significantly over the next 50 min. In PI fed 30 mllkg, the mean GRV was 32% at 30 min and did not change significantly thereafter. Except at 20 rnin, the mean GRV was significantly greater at all intervals in the PI fed 10 ml/kg compared to 30 mllkg. Conclusions: In the healthy PI, 1) there is no significant difference in GEP during the first hr after feeding in PI fed equal volumes of S or L; 2) the mean GRV varies with the volume of F fed.
MICROMETHOD FOR THE RAPID ANAL'fSIS OF PLASMA LIPIDS. Howard R. Sloan, Constance Seckel, Benn Kerzner. The quantitation of plasma triglycerides (TG), cholesterol (C), cholesteryl esters (CE), and fatty acids (FFA) presently requires expensive, time-consuming multiple analyses; sample volumes are too large to permit repeated assays in the newborn. To overcome these problems, we have developed a thin-layer chromatographic (TLC) technique which simultaneously estimates these lipids. Blood is drawn into a 44.7~1 heparinized capillary tube. One to ten ul of plasma is applied directly to the aquaphilic, preadsorbent area of a silica gel TLC plate. After thorough drying, the plate i s developed to lOcm (20 minutes) with petroleum ether:ethyl ether: acetic acid-90:lO:l which quantitatively extracts the four lipids from the plasma and readily separates them. Color is developed with a cupric acetate stain, and the lipid content of each spot is estimated by visual comparison with standards or quantified by photodensitometry. This technique provides linear color responses over these ranges: TG, .5-10pg; C, .3-5pg; CE, .5 5pg; FFA, .5-5ug, quantities present in lop1 of normal or hyperlipemic plasma. The method's accuracy is ? 5% and its precision is ? 3%. Results are available within ninety minutes and the estimated cost is approximately one dollar per test. With TLC we have: determined the C, CE, and TG content of normal and hyperlipemic plasma; monitored on a daily, and even hourly basis, lipid levels of small premature infants receiving IV fat; andscreened for hyperlipidemia. This microtechnique should facilitate the study of fat metabolism in infants.
Strong Memorial Hospital, Department of Pediatrics, Rochester, NY.
chronic nonspecific diarrhea of childhood (CNDC) is a common and frequently frustrating problem seen between 6 and 30 months of age. It is characterized by 2 or more loose, voluminous, foul smelling stools per day for more than 4 weeks, unassociated with pain or failure to thrive. The etiology of this disorder is unknown and little information as to proper treatment is available.
In order to assess bulk agents as therapy in this problem, 19 consecutive children with the clinical diagnosis of CNDC were studied. A 24 hour diet recall and stool examination for parasites, bacteria, occult blood, pH, and carbohydrate were obtained. All patients were negative for carbohydrate intolerance and occult blood. One child had campylobacter and 2 had giardia as the cause of their diarrhea. Sixteen remaining children were treated first with an unrestricted diet for 1 week, then psyllium containing bulk agents for 2 weeks (1 tbsp bid), and if no response, cholestyramine (2% gms qid) for 2 weeks. 81% of the patients responded to therapy. Three (19%) responded to normalization of the diet only, 9 (56%) to psyllium, and 1 (6%) to cholestyramine. Only 3 (19%) did not respond. Of the patients who responded, most did so promptly and required only 2-3 weeks of therapy. A therapeutic approach consisting of normalization of the diet and bulk agents seems to be an effective mode of therapy in this common childhood disorder. W e compared medical and surgical treatment o f GER i n 31 severel y retarded children (mean age 15.9 y r ; IQ<20) t o define r e l a t i v e r i s k and effectiveness o f each method and develop treatment guidel i n e s f o r t h i s special p a t i e n t group. A t diagnosis a l l 31 were treated > 8 wks w i t h antacids, small frequent feedings, elevation o f head and i n 2 bethanechol. I n 8 "responders"(26%) symptoms cleared completely(4) o r p a r t i a l l y ( 4 ) . O f 23 medical failures, 14 underwent Nissen fundoulication and aastrostomv. I n 9 medical " f a i l u r e s " surgery was' refused and medical theFapy was continued. Results are below. *=effected a t l a s t v i s i t l i n i t i a l l y effected. 2, gas bloat-2, herniated p l i c a t i b n -2 , i n t e s t i n a i obsiruction-2, infection-2, g a s t r i c leak-1, esophageal s t r i c t u r e -1 . Growth failure is a frequent problem in children with congenital heart disease. Since chronic hypozincemia can also causa growth retardation, fasting plasma zincs were obtained in 69 children undergoing cardiac catheterization to determine if zinc deficiency was related to growth delay in these patients. The mean plasma zinc for this group was 87pg/dl (Range: 46-152) which is comparable to published normals. Ages ranged from 1 day to 21 years.
MEDICAL VS SURGICAL MANAGEMENT OF GASTROESOPHAGEAL REFLUX (GER) IN
Patients with zinc levels in the low 20% (< 72pg/dl) were then compared to the remainder of the group for weight percentile, age, use of chronic digoxin for heart failure, and presence of Downs Syndrome. Chi-squared analysis showed:
Weight < 5th percentile Only 2 patients were on chronic furosemide, a potent zincuric, but one of these had the second lowest zinc, 48pg/dl. We conclude that hypozincemia is frequently seen in growth retarded children with congenital heart disease. However, this was not related to digoxin therapy for chronic congestive heart failure or the presence of Downs Syndrome in these children. 
